This compound was ranked 155th out of 71,000 Ugi products for docking with falcipain-2 at potential receptor site V1 (see full description by Rajarshi Guha here).
This compound, along with another (EXP148) that crystallized similarly, have been shipped to the Rosenthal group at UCSF for testing against the malarial parasite and hopefully get some falcipain-2 inhibition assay results. That way we'll be able to investigate the validity of our docking model.
I'll be posting updates on this blog but the status of any shipped compounds will be maintained on the isolated compounds table.
If anyone would like to run their own assays please contact us. We would be happy to ship any of these compounds, as long as our collaborators are willing to work under Open Notebook conditions.
The beauty of screening for products that are purified by crystallization is that, if any of these prove to be useful for any application, it should be very simple and cheap to produce several kilograms. This can come in handy for end users with very limited resources.